Published Aug 19, 2019

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Member News
Copy The Link to the  Article
Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma
Copy The Link to the  Article

Related or similar articles

View more News
January 3, 2025

Exciting Equipment Additions to Labshares: Innovating Your Research

Labshares News
March 13, 2019

Labshares Newton Grows its Business​

Labshares is unveiling a major rennovation
Labshares News
June 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

The MoU was signed during the official, 40thanniversary celebration ceremony of the Shanghai-Rotterdam Sister City Relationship.
Member News